| NCT06683742 | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-11-27 | 2027-10 | 2026-10 |
| NCT06668064 | A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 | ACTIVE_NOT_RECRUITING | PHASE3 | 2024-10-22 | 2027-08 | 2026-08 |
| NCT06099184 | Study of EYP-1901 in Patients With Diabetic Macular Edema (DME) | COMPLETED | PHASE2 | 2024-01-15 | 2024-10-24 | 2024-10-24 |
| NCT05383209 | Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR) | COMPLETED | PHASE2 | 2022-09-28 | 2024-05-06 | 2024-02-12 |
| NCT05550350 | A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery | WITHDRAWN | PHASE3 | 2022-09 | 2023-09 | 2023-09 |
| NCT05550363 | A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery (2) | WITHDRAWN | PHASE3 | 2022-09 | 2023-09 | 2023-09 |
| NCT05381948 | Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) | COMPLETED | PHASE2 | 2022-06-30 | 2024-04-24 | 2023-11-29 |
| NCT05191706 | Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract | RECRUITING | PHASE4 | 2022-01-04 | 2026-02 | 2026-01 |
| NCT05070728 | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert | TERMINATED | PHASE3 | 2021-10-13 | 2023-04-12 | 2023-04-12 |
| NCT04747197 | First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD) | COMPLETED | PHASE1 | 2021-01-20 | 2022-05-11 | 2022-05-11 |
| NCT04511650 | Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019 | TERMINATED | PHASE2 | 2020-10-21 | 2021-02-26 | 2021-02-26 |
| NCT04405245 | Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma | COMPLETED | PHASE2 | 2020-06-06 | 2020-11-05 | 2020-11-05 |
| NCT03197870 | The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) | COMPLETED | PHASE2 | 2017-06-09 | 2019-02-09 | 2019-01-09 |
| NCT02748512 | Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis | COMPLETED | PHASE3 | 2016-02-23 | 2017-08-17 | 2017-08-17 |
| NCT02746991 | Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis | COMPLETED | PHASE3 | 2015-06-02 | 2019-10-04 | 2019-10-04 |
| NCT01694186 | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert | COMPLETED | PHASE3 | 2013-08-02 | 2018-03-26 | 2018-03-26 |